不同剂量阿托伐他汀对不稳定型心绞痛患者白介素-6和高敏C-反应蛋白的影响

不同剂量阿托伐他汀对不稳定型心绞痛患者白介素-6和高敏
C-反应蛋白的影响
张旭;孙振学;吕豪
【期刊名称】《河北医药》
【年(卷),期】2012(034)002
【摘要】Objective To investigate the effects of different doses of atorvastatin on interleukin-6 ( IL-6) and hypersensitive C-reactive protein ( hs-CRP) in patients with unstable angina pectoris ( UAP) . Methods 94 patients with UAP were randomly divided into three groups: the patients in control group were given routine therapy,the patients in control treatment group,on the basis of control group,were given atorvastatin 10mg,and the patients in treatment group were given atorvastatin 20mg, besides the conventional therapy. The levels of blood lipids, IL-6, hs-CRP were detected before and after the treatments. Results After treatment, the levels of blood lipids, IL-6 and hs-CRP in control treatment group and treatment group were significantly reduced, as compared with those before treatment ( P <0.01) ,furthermore the decrease in treatment group was more obvious than that in control treatment group ( P < 0. 01 ) , however, the decrease of blood lipid levels before treatment in control treatment group and treatment group was not related with the decrease of levels of IL-6 and hs-CRP ( P > 0. 05 ). Conclusion The atorvastatin can reduce the levels of blood lipid,IL-6 and hs-CRP in patients with UAP,and
the effect of atorvastatin 20mg is superior to that of atorvastatin l0mg, however, its anti-inflammatory effect is not independent of the effect of reducing blood lipid.%目的探讨不同剂量阿托伐他汀对不稳定型心绞痛患者白介素-6(IL-6)和高敏C-反应蛋白(hs-CRP)的影响.方法 94例不稳定型心绞痛患者随机分为3组,对照组给予常规治疗,对照治疗组在常规治疗基础上给予阿托伐他汀10 mg/d,治疗组在常规治疗基础上给予阿托伐他汀20 mg/d,测定治疗前后血脂、IL-6及hs-CRP的变化.结果对照治疗组及治疗组在治疗后血脂、IL-6及hs-CRP水平较治疗前均有显著下降(P＜0.01),且治疗组较对照治疗组下降更明显(P＜0.01);对照治疗组及治疗组治疗前后血脂下降与IL-6及hs-CRP下降无相关性(P＞0.05).结论阿托伐他汀可降低不稳定型心绞痛患者的血脂、IL-6及hs-CRP水平,20 mg 优于10 mg,其抗炎作用不依赖降脂作用.
【总页数】2页(P175-176)
【作者】张旭;孙振学;吕豪
【作者单位】100089 北京市,武警总部机关门诊部保健科;100089 北京市,武警总部机关门诊部保健科;武警北京市总队第二医院心内科
【正文语种】中文
【中图分类】R541.4
【相关文献】
1.早期应用阿托伐他汀对不稳定型心绞痛患者高敏C-反应蛋白水平的影响 [J], 武海宁
2.不同剂量瑞舒伐他汀对老年不稳定型心绞痛患者血清同型半胱氨酸及高敏C-反应蛋白水平的影响 [J], 吴志红;孙玉然;连晓芳;王香玲;任岩春;都伟;王云英;安少波;
徐雷
3.不同剂量瑞舒伐他汀钙对不稳定型心绞痛患者的血脂、血清高敏C-反应蛋白及同型半胱氨酸的影响 [J], 宋炳慧;宋晓光;贾珊珊;魏冬梅
4.阿托伐他汀联合麝香保心丸对不稳定型心绞痛患者高敏C-反应蛋白水平的影响[J], 符会妮;吕树志
5.不同剂量阿托伐他汀对急性脑梗死患者高敏C-反应蛋白及基质金属蛋白酶9的影响 [J], 曹云友
因版权原因，仅展示原文概要，查看原文内容请购买。